TY  - GEN
AU  - Ferrannini,E
AU  - Seman,L
AU  - Seewaldt-Becker,E
AU  - Hantel,S
AU  - Pinnetti,S
AU  - Woerle,H J
TI  - A Phase IIb, randomized, placebo-controlled study of the SGLT2 inhibitor empagliflozin in patients with type 2 diabetes
SN  - 1463-1326
PY  - 2014///0311
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Argentina
KW  - epidemiology
KW  - Benzhydryl Compounds
KW  - administration & dosage
KW  - Blood Glucose
KW  - Body Weight
KW  - Diabetes Mellitus, Type 2
KW  - blood
KW  - Dose-Response Relationship, Drug
KW  - Double-Blind Method
KW  - Drug Therapy, Combination
KW  - Europe
KW  - Female
KW  - Glucosides
KW  - Glycated Hemoglobin
KW  - metabolism
KW  - Humans
KW  - Hypoglycemic Agents
KW  - Male
KW  - Metformin
KW  - Middle Aged
KW  - Nasopharyngitis
KW  - chemically induced
KW  - Republic of Korea
KW  - Russia
KW  - Sodium-Glucose Transporter 2 Inhibitors
KW  - Taiwan
KW  - Thirst
KW  - Treatment Outcome
KW  - Ukraine
KW  - Urination Disorders
KW  - Weight Loss
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1111/dom.12081
ER  -